ECHOPULSE
ECHOPULSE is a medical device with 12 clinical trials. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
90.9%
10 of 11 finished
9.1%
1 ended early
0
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment of Breast Fibroadenoma Targeted Tissue With HIFU
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
HIFU Ablation vs Fixed-dose RAI-131 Therapy in Moderate-sized Non-toxic MNG
A Trial Comparing USG-HIFU vs AS in Management of Low-risk PTMC
HIFU vs RAI in the Relapsed Graves' Disease
Clinical Trials (12)
Treatment of Breast Fibroadenoma Targeted Tissue With HIFU
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
HIFU Ablation vs Fixed-dose RAI-131 Therapy in Moderate-sized Non-toxic MNG
A Trial Comparing USG-HIFU vs AS in Management of Low-risk PTMC
HIFU vs RAI in the Relapsed Graves' Disease
Treatment of Breast Fibroadenoma With FastScan HIFU
Treatment of Benign Thyroid Nodules With FastScan HIFU
HIFU in Patients With Non-malignant Thyroid Nodules
Treatment of Insufficient Superficial and Perforating Veins of the Lower Limb Using HIFU
HIFU Reapplication in Benign Nodules
Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)
A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Benign Thyroid Nodules
All 12 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 12